Fernández-Escobar, Mercedes
Calero-Bernal, Rafael
Benavides, Julio
Regidor-Cerrillo, Javier
Guerrero-Molina, María Cristina
Gutiérrez-Expósito, Daniel
Collantes-Fernández, Esther
Ortega-Mora, Luis Miguel
Funding for this research was provided by:
Spanish Ministry of Science and Innovation (AGL2016-75935-C2-R)
Autonomous Community of Madrid (PLATESA2-CM-P2018/BAA-4370)
Article History
Received: 4 May 2020
Accepted: 30 July 2020
First Online: 5 August 2020
Change Date: 3 November 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Animal procedures for the bioassay in mice were approved by the Animal Welfare Committee of the Community of Madrid, Spain (PROEX 274/16, section 2.1.3), following proceedings described in Spanish and EU legislation (Law 32/2007, R.D. 53/2013, and Council Directive 2010/63/EU). All animals used in this study were handled in strict accordance with good clinical practices, and all efforts were made to minimize suffering. As a humane endpoint, mice exhibiting significant weight loss or nervous clinical signs were culled to limit unnecessary suffering.
: Not applicable.
: The authors declare that they have no competing interests.